GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
88 hedge funds and large institutions have $345M invested in GenMark Diagnostics, Inc in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 9 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 26
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
1% less funds holding
Funds holding: 89 → 88 (-1)
12% less capital invested
Capital invested by funds: $392M → $345M (-$47.2M)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $272K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadian Capital Management
New York
|
+$11.5M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$11.3M |
| 3 |
VAM
Visium Asset Management
New York
|
+$2.9M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.31M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$8.1M |
| 2 |
FAM
Fred Alger Management
New York
|
-$3.76M |
| 3 |
Parnassus Investments
San Francisco,
California
|
-$2.99M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$2.72M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.32M |
GNMK Hedge Fund Activity: Q3 2015 in Review
88 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2015, worth a combined $345M — down 12% from $392M a quarter earlier.
Fund positioning in GNMK was balanced in Q3 2015: 9 funds opened new positions, 9 closed out, 39 added to existing stakes and 26 trimmed.
The largest buyer was Cadian Capital Management, adding an estimated $11.5M. The largest seller was JP Morgan Chase, cutting an estimated $8.1M.
- 88 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2015, down from 89 in Q2 2015.
- Funds reported $345M of GenMark Diagnostics, Inc stock for Q3 2015, down 12% quarter-over-quarter.
- 9 funds opened new GenMark Diagnostics, Inc positions in Q3 2015 and 9 closed out, a net change of 0 holders.
- The largest GenMark Diagnostics, Inc buyer in Q3 2015 was Cadian Capital Management, an estimated $11.5M added.
- The largest GenMark Diagnostics, Inc seller in Q3 2015 was JP Morgan Chase, an estimated $8.1M sold.
Based on aggregated 13F filings for Q3 2015.